Unknown

Dataset Information

0

Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).


ABSTRACT: Statins, widely prescribed for cardiovascular diseases, are also being eyed for management of age-related macular degeneration (AMD). Poor bioavailability and blood-aqueous barrier may however limit significant ocular concentration of statins following oral administration. We for the first time propose and investigate local application of atorvastatin (ATS; representative statin) loaded into solid lipid nanoparticles (SLNs), as self-administrable eye drops. Insolubility, instability, and high molecular weight >?500 of ATS, and ensuring that SLNs reach posterior eye were the challenges to be met. ATS-SLNs, developed (2339/DEL/2014) using suitable components, quality-by-design (QBD) approach, and scalable hot high-pressure homogenization, were characterized and evaluated comprehensively for ocular suitability. ATS-SLNs were 8 and 12 times more bioavailable (AUC) in aqueous and vitreous humor, respectively, than free ATS. Three-tier (in vitro, ex vivo, and in vivo) ocular safety, higher corneal flux (2.5-fold), and improved stability (13.62 times) including photostability of ATS on incorporation in ATS-SLNs were established. Autoclavability and aqueous nature are the other highlights of ATS-SLNs. Presence of intact fluorescein-labeled SLNs (F-SLNs) in internal eye tissues post-in vivo application as eye drops provides direct evidence of successful delivery. Perinuclear fluorescence in ARPE-19 cells confirms the effective uptake of F-SLNs. Prolonged residence, up to 7 h, was attributed to the mucus-penetrating nature of ATS-SLNs. Graphical abstract.

SUBMITTER: Yadav M 

PROVIDER: S-EPMC7223242 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).

Yadav Monika M   Schiavone Nicola N   Guzman-Aranguez Ana A   Giansanti Fabrizio F   Papucci Laura L   Perez de Lara Maria J MJ   Singh Mandeep M   Kaur Indu Pal IP  

Drug delivery and translational research 20200801 4


Statins, widely prescribed for cardiovascular diseases, are also being eyed for management of age-related macular degeneration (AMD). Poor bioavailability and blood-aqueous barrier may however limit significant ocular concentration of statins following oral administration. We for the first time propose and investigate local application of atorvastatin (ATS; representative statin) loaded into solid lipid nanoparticles (SLNs), as self-administrable eye drops. Insolubility, instability, and high mo  ...[more]

Similar Datasets

| S-EPMC8204663 | biostudies-literature
| S-EPMC5886461 | biostudies-literature
| S-EPMC7460693 | biostudies-literature
| S-EPMC3880448 | biostudies-other
| S-EPMC11331923 | biostudies-literature
| S-EPMC8464988 | biostudies-literature
| S-EPMC7079812 | biostudies-literature
| S-EPMC5804860 | biostudies-literature
| S-EPMC2854213 | biostudies-literature
| S-EPMC5816845 | biostudies-literature